4//SEC Filing
Stone Paul A. 4
Accession 0001567619-20-012462
CIK 0001676725other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 7:46 PM ET
Size
11.3 KB
Accession
0001567619-20-012462
Insider Transaction Report
Form 4
Stone Paul A.
SVP, General Counsel
Transactions
- Exercise/Conversion
Common Stock
2020-06-17$4.62/sh+3,100$14,322→ 18,100 total - Exercise/Conversion
Stock Option (right to buy)
2020-06-17−3,100→ 137,832 totalExercise: $4.62Exp: 2028-06-20→ Common Stock (3,100 underlying) - Sale
Common Stock
2020-06-17$17.50/sh−2,500$43,749→ 15,600 total - Sale
Common Stock
2020-06-17$19.95/sh−600$11,968→ 15,000 total
Footnotes (4)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades in prices ranging from $17.48 to $17.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]This transaction was executed in multiple trades in prices ranging from $19.83 to $19.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]25% of the shares subject to the option vest on the first anniversary measured from May 2, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
IDEAYA Biosciences, Inc.
CIK 0001676725
Entity typeother
Related Parties
1- filerCIK 0001777511
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 7:46 PM ET
- Size
- 11.3 KB